CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $6.06 | $101K | 1,176,506 |
| 2026-05-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $6.23 | $104K | 1,193,173 |
| 2026-04-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $5.99 | $100K | 1,209,840 |
| 2026-03-30 | Brady James Aloysius Director | Sale 10b5-1 | −10,834 | $5.54 | $60K | 89,166 |
| 2026-03-12 | McCulloch Kevin See Remarks | Option exercise | +48,894 | $4.09 | $200K | 1,777,721 |
| 2026-03-12 | McCulloch Kevin See Remarks | Option exercise | +4 | $3.94 | $16 | 1,777,725 |
| 2026-03-12 | McCulloch Kevin See Remarks | Option exercise · Stock Option (Right to Buy) | −48,894 | $4.09 | $200K | 43,773 |
| 2026-03-12 | McCulloch Kevin See Remarks | Option exercise · Stock Option (Right to Buy) | −4 | $3.94 | $16 | 79,996 |
| 2026-03-05 | Pieper Steven See Remarks | Option exercise | +27,891 | $4.09 | $114K | 1,394,904 |
| 2026-03-05 | Pieper Steven See Remarks | Option exercise | +14,036 | $5.93 | $83K | 1,408,940 |
| 2026-03-05 | Pieper Steven See Remarks | Option exercise · Stock Option (Right to Buy) | −27,891 | 0 | ||
| 2026-03-05 | Pieper Steven See Remarks | Option exercise · Stock Option (Right to Buy) | −14,036 | 0 | ||
| 2026-03-02 | Hecht Beth See Remarks | Sale 10b5-1 | −16,567 | $6.24 | $103K | 1,226,607 |
| 2026-03-02 | Hecht Beth See Remarks | Sale 10b5-1 | −100 | $7.06 | $706 | 1,226,507 |
| 2026-02-24 | Nguyen Anh Tu See Remarks | Shares withheld for taxes | −29,300 | $6.88 | $202K | 395,023 |
| 2026-02-02 | Hecht Beth See Remarks | Sale | −16,667 | $7.45 | $124K | 1,243,174 |
| 2026-01-31 | McCulloch Kevin See Remarks | Shares withheld for taxes | −68,454 | $7.36 | $504K | 1,785,435 |
| 2026-01-31 | McCulloch Kevin See Remarks | Shares withheld for taxes | −30,289 | $7.36 | $223K | 1,755,146 |
| 2026-01-31 | McCulloch Kevin See Remarks | Shares withheld for taxes | −27,319 | $7.36 | $201K | 1,727,827 |
| 2026-01-31 | Pieper Steven See Remarks | Shares withheld for taxes | −111,765 | $7.36 | $823K | 1,460,782 |
Page 3 of 10 · 200 trades